Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26033158 | 0.78 | POLB (0.40) | POLBALDH1A1GAALMNATP53 | |
| SCHEMBL25835917 | 0.77 | POLB (0.41) | POLBALDH1A1GAALMNATP53 | |
| SCHEMBL26036326 | 0.75 | CXCR4 (0.34) | POLBALDH1A1GAALMNATP53 | |
| SCHEMBL26048769 | 0.74 | L3MBTL1 (0.30) | L3MBTL1 | |
| SCHEMBL26037656 | 0.70 | L3MBTL1 (0.32) | L3MBTL1 | |
| SCHEMBL25836299 | 0.69 | DRD2 (0.38) | POLBCXCR4 | |
| SCHEMBL26032119 | 0.69 | POLB (0.36) | POLBALDH1A1LMNATP53MAPT | |
| SCHEMBL26032132 | 0.69 | POLB (0.36) | POLBALDH1A1LMNATP53MAPT | |
| SCHEMBL25850274 | 0.64 | CNR1 (0.32) | ALDH1A1MAPTSMN1; SMN2 | |
| SCHEMBL25835923 | 0.64 | POLB (0.33) | L3MBTL1POLBALDH1A1GAALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024086633-A1 | RNAI AGENTS FOR INHIBITING EXPRESSION OF DM1 PROTEIN KINASE (DMPK) COMPOSITIONS THEREOF, AND METHODS OF USE | Arrowhead Pharmaceuticals, Inc. (US) | 2024-04-25 | — | — | WO | disclosed |